Evaluating Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma-Reply
- PMID: 35080629
- DOI: 10.1001/jamasurg.2021.7114
Evaluating Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma-Reply
Comment on
-
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.JAMA Surg. 2021 Aug 1;156(8):721-729. doi: 10.1001/jamasurg.2021.2373. JAMA Surg. 2021. PMID: 34160577 Free PMC article. Clinical Trial.
-
Evaluating Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma.JAMA Surg. 2022 May 1;157(5):458-459. doi: 10.1001/jamasurg.2021.7113. JAMA Surg. 2022. PMID: 35080625 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical